499770-63-7

Usage

Chemical Properties

Colorless liquid or white crystal

InChI:InChI=1/C6H11N3/c1-5-3-6(4-7)9(2)8-5/h3H,4,7H2,1-2H3

Upstream product

• 57012-20-1 (1,3-dimethyl-1H-pyrazol-5-yl)methanol 
• 10250-59-6 1,3-dimethyl-1H-pyrazole-5-carboxylic acid methyl ester 
• 25016-09-5 1,3-dimethyl-1H-pyrazole-5-carbaldehyde 
• 1182281-77-1 2,5-dimethyl-2H-pyrazole-3-carbaldehyde oxime 
• 306936-77-6 1,3-dimethyl-1H-pyrazole-5-carbonitrile 

Downstream Products

• 1182280-64-3 N-(2,5-dimethyl-2H-pyrazol-3-ylmethyl)-4-(5-trifluormethyl-pyridin-2-yloxy)-benzenesulfonamide 
• 1344707-54-5 (R/S)-N-((1,3-dimethyl-1H-pyrazol-5-yl)methyl)-2-hydroxy-2-(4-(5-(3-phenyl-4-(trifluoromethyl)isoxazol-5-yl)-1,2,4-oxadiazol-3-yl)phenyl)acetamide trifluoroacetate 

Relevant academic research and scientific papers

SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS

The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful fungi,

2-(1H-INDAZOL-6-YLAMINO)-BENZAMIDE COMPOUNDS AS PROTEIN KINASES INHIBITORS USEFUL FOR THE TREATMENT OF OPHTALMIC DISEASES

Indazole compounds that modulate and/or inhibit the ophthalmic diseases and the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating ophthalmic diseases and cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma,rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.